U.S. Tortugas Neuroscience Raises $106 Million and Fully Launches
NQ Score
81/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Tortugas Neuroscience, a US biotech focused on CNS disorders, raised $106 million in Seed and Series A funding to advance Phase 2 trials for novel oral drugs licensed from Eisai and Hansoh Pharma.